CClinicalTrials.gg
Approved for marketingNCT00584064Updated Apr 11, 2019

Emergency/Compassionate Use PFO Occluder

An expanded access record providing Device closure with the AMPLATZER PFO Occluder in Patent Foramen Ovale and PFO, sponsored by Abbott Medical Devices. Approved for marketing. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2019-04-11.

Sponsored by Abbott Medical Devices · Expanded access

Study type
Expanded access
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Emergency/compassionate use for the AMPLATZER PFO Occluder

02

Conditions studied

  • Patent Foramen Ovale
  • PFO

Browse trials for

Keywords

  • patent
  • foramen
  • ovale
  • PFO
03

In context

Foramen Ovale, Patent

134 studies on the registry are indexed under Foramen Ovale, Patent; 46 are open to participants now.

Browse Foramen Ovale, Patent studies →

Lead sponsor

Abbott Medical Devices is the lead sponsor of 525 studies on the registry; 35 are open to participants now.

Of its 52 completed or terminated interventional studies of FDA-regulated products, 43 (83%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All

Eligibility criteria

Inclusion Criteria:

  • Emergency/compassionate use for patients not meeting the inclusion criteria for the AMPLATZER PFO Access Registry.
05

Access details

Study type
Expanded access

Available treatment

  • DeviceDevice closure with the AMPLATZER PFO Occluder

    Device closure with the AMPLATZER PFO Occluder

06

Where to request access

No study locations are listed for this record.

07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 11, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00584064
Lead sponsor
Abbott Medical Devices
Responsible party
Sponsor
First posted
Jan 2, 2008
Last update
Apr 11, 2019
View the source record on ClinicalTrials.gov ↗

Requesting access

Expanded access is arranged between your doctor and the company. Ask your care team to contact the provider listed on this record.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion